Reduced forced vital capacity is independently associated with ethnicity, metabolic factors and respiratory symptoms in a Caribbean population: a cross-sectional study
grid.430529.9Faculty of Medical Sciences, Department of Clinical Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago
grid.430529.9Dean’s Office, Faculty of Medical Sciences, The University of The West Indies, St. Augustine Campus, St. Augustine, Trinidad and Tobago
South-West Regional Health Authority, San Fernando, Trinidad and Tobago
0000 0001 2113 8111grid.7445.2National Heart and Lung Institute, Imperial College, London, UK
Abstract
Background
Relationships between low forced vital capacity (FVC), and morbidity have previously been studied but there are no data available for the Caribbean population. This study assessed the association of low FVC with risk factors, health variables and socioeconomic status in a community-based study of the Trinidad and Tobago population.
Methods
A cross-sectional survey was conducted using the Burden of Obstructive Lung Disease (BOLD) study protocol. Participants aged 40 years and above were selected using a two-stage stratified cluster sampling. Generalized linear models were used to examine associations between FVC and risk factors.
Results
Among the 1104 participants studied a lower post-bronchodilator FVC was independently associated with a large waist circumference (− 172 ml; 95% CI, − 66 to − 278), Indo-Caribbean ethnicity (− 180 ml; 95% CI, − 90 to − 269) and being underweight (− 185 ml; 95% CI, − 40 to − 330). A higher FVC was associated with smoking cannabis (+ 155 ml; 95% CI, + 27 to + 282). Separate analyses to examine associations with health variables indicated that participants with diabetes (p = 0∙041), history of breathlessness (p = 0∙007), and wheeze in the past 12 months (p = 0∙040) also exhibited lower post-bronchodilator FVC.
Conclusion
These findings suggest that low FVC in this Caribbean population is associated with ethnicity, low body mass index (BMI), large waist circumference, chronic respiratory symptoms, and diabetes.
Electronic supplementary material
The online version of this article (10.1186/s12890-019-0823-9) contains supplementary material, which is available to authorized users.
Introduction
More than one and a half centuries after Hutchinson’s design of a spirometer to determine the ‘capacity for life,’ the forced vital capacity (FVC) remains a good predictor of mortality and morbidity. It is related to all-cause mortality even in the general population [1, 2] and can predict it better than systolic blood pressure or body mass index (BMI) [3]. Studies from the developed world have also shown significant associations of FVC with cardiovascular disease [4, 5], cardiovascular events [6], sudden cardiac death [7], metabolic syndrome [8], diabetes [9, 10], and the progression of chronic kidney disease [11]. There are relatively few studies that have examined the risk factors for a low FVC though this has often been attributed to “normal” ethnic differences.
Few spirometry based studies have been conducted on the Caribbean population. These studies have focused on airway obstruction and were performed either in specialty clinics or hospital. Two of them showed low forced expiratory volume in one second (FEV1) or FVC associated with vascular disease [12, 13] and another, FVC with systemic inflammation in diabetic patients [14].
We studied FVC in a national community-based study of non-institutionalized adults aged 40 years and over and living in Trinidad and Tobago, using the Burden of Obstructive Lung Disease (BOLD) study methodology. We investigated potential risk factors as well as the relation of FVC to the health and socioeconomic status. Since the use of universal cut-offs to define abnormal spirometry is contentious [15], we have analysed FVC as a continuous variable to assess its associations, including those with age, sex and ethnicity. In addition, we also studied similar associations with pre-bronchodilator FVC; and pre and post-bronchodilator FEV1.
Methods
Setting
Trinidad and Tobago, a high human development indexed country in the Caribbean, has a uniquely diverse population of predominantly East Indian and African descent. More than half of the population aged 20 years or more (55.5% of males and 66.1% of females) are overweight and obese [16]. The country also possesses a high burden of diabetes and cardiovascular diseases which were determined as the top two causes of death and disability in 2016 (Data was sourced from the IHME GBD profile. http://www.healthdata.org/trinidad-and-tobago.).
Study design
A cross-sectional survey was conducted across the 15 administrative districts of Trinidad and Tobago, a country with about 1.3 million inhabitants including 39% aged 40 years and above [17]. The study was approved by the ethics committees of the Faculty of Medical Sciences of the University of the West Indies and the Ministry of Health, Trinidad and Tobago.
After obtaining consent, participants aged 40 years and above were asked to answer a core questionnaire focusing on respiratory symptoms, health status, activity limitation, use of healthcare services, and exposure to potential risk factors, such as cigarette smoke. The participants also performed spirometry if there were no contraindications for forced expiratory manoeuvres. Additional questionnaires on indoor air pollution and occupational exposures were administered before the post-bronchodilator spirometry manoeuvres. A wealth score, using a Mokken scale [18] was applied to differentiate the socio-economic status of individual participants. This score was calculated based on the ownership of 10 household assets.
Spirometry
Spirometry was performed according to the 1994 American Thoracic Society (ATS) criteria [19], using the Easy-One portable spirometer (ndd Medizintechnik; Zurich, Switzerland), with the participant in a seated position and pre and post-bronchodilator spirometry (15 min after administering 200 μg salbutamol via metered-dose inhaler with a valve spacer) performed following the BOLD methodology [20]. The difference between the largest and second largest FEV1 and FVC values of < 200 ml was considered as reproducible [20]. A plateau for at least one second after an exhalation time of at least 6 s was considered as a valid end-of-test criterion [19]. Spirometry data were transmitted electronically to the BOLD pulmonary function reading centre in London, where each spirogram was reviewed. A good spirometry had to meet ATS criteria for acceptability, including having at least three attempts, two of which were acceptable [21]. Spirometry technicians were continuously monitored and whenever their quality scores dropped below a pre-set level, they were asked to stop testing, and undergo retraining and recertification. Among the acceptable efforts, the best post-bronchodilator FEV1 and FVC values, even if they were from different curves were used for statistical analyses [19].
Sampling
Participants were selected using two-stage stratified cluster sampling. The study was based on the BOLD protocol that required a minimal sample size of 600 persons above the age of 40 years. The actual sample size, inflated to take into account an expected rate of non-response and unacceptable spirometry (20%) and the clustered nature of the sampling, was 1209 households. A total of 1469 eligible participants were identified from these households and invited to participate.
Statistical analyses
Chi-square tests were used to examine differences in categorical variables and Student’s t-test to examine differences in continuous variables. We checked for differences between responders and non-responders and between those with and without acceptable spirometry. Complex Samples General Linear Models (SPSS Version 25) were used to study associations between FVC and the risk factors. This enabled the application of the stratified cluster sampling structure of the data in the analysis. Weights were also used in the analyses. Base weights were calculated as the inverse of the probability of each participant’s selection. Final weights were determined by adjusting for the age and gender distribution of the national population, using census data.
Age, sex, height, and height-squared are strong predictors of lung function [22] and as these four variables accounted for 60.5% of FVC variance, they were entered as covariates in all analyses. Age squared was not a significant predictor in our analyses and was not used as a covariate. Separate analyses were conducted for each risk factor. All the risk factors that were significantly associated with FVC were subsequently entered in a final model to determine independent predictors. We also used General Linear Models to conduct separate regression analyses to examine associations between FVC and the various health status indicators, and respiratory symptoms. The Complex Samples Analysis module was also used to estimate the prevalence and 95% CI for chronic airflow obstruction.
Results
Out of a total eligible sample of 1469 individuals, 1394 completed the core questionnaire and undertook spirometry. Among them, 1104 successfully performed spirometry, as per the BOLD study quality control criteria (Fig. 1). Of the individuals approached 95% responded (95% response rate) and of these 97% agreed to participate (97% co-operation rate). Spirometry acceptability rate was 79%. Younger participants, those of Indo-Caribbean descent and those who had no chronic respiratory symptoms had higher rates of acceptable spirometry (p < 0.005 in all cases) (Additional file 1: Table S1). Smoking status, BMI and the presence of doctor-diagnosed respiratory disease did not show association with the participants’ spirometry acceptability.
The majority of participants were females (60%), and the sample’s age and ethnic distributions matched well with the recent national census data [17]. Overall, the sample comprised mainly persons of Asian or African ancestry (78%), with secondary or higher level education (53%), who were overweight or obese (70%), and who were exposed to indoor air pollutants (55%) (Table 1). Mean BMI and waist circumferences were higher among Afro-Caribbeans than Indo-Caribbeans (29.59 kg/m2 vs. 27.90 kg/m2; 97.71 cm vs. 95.71 cm, respectively; p < 0.03 in all cases). 27% of the participants gave a history of smoking, which was four times more prevalent in males than females. Among the smokers, more than half were current smokers and one third had also smoked cannabis. 85% of participants had ownership of eight or more of the household amenities in the inventory.Variable Male (443) Female (661) Total (1104) Age in years 40–49 152 (34.3%) 287 (43.4%) 439 (39.8%) 50–59 145 (32.7%) 193 (29.2%) 338 (30.6%) 60–69 90(20.3%) 117 (17.7%) 207 (18.8%) 70+ 56 (12.6%) 64 (9.7%) 120 (10.9%) Ethnicity Indo-Caribbean 191 (43.1%) 269 (40.7%) 460 (41.7%) Afro-Caribbean 169 (38.1%) 233 (35.2%) 402 (36.4%) Mixed/ other 83 (18.7%) 159 (24.1%) 242 (21.9%) Highest completed level of education Primary /none 205 (46.8%) 314 (47.5%) 521 (47.2%) Secondary 134 (30.2%) 216 (32.7%) 350 (31.7%) Vocational 79 (17.8%) 90 (13.6%) 169 (15.3%) University 23 (5.2%) 41 (6.2%) 64 (5.8%) Employment status Employed 287 (64.8%) 328 (49.6%) 615 (55.7%) Not working 17 (3.5%) 23 (3.5%) 40 (3.6%) House-person 7 (1.6%) 208 (31.5%) 215 (19.5%) Retired 122 (27.5%) 88 (13.3%) 210 (19.0%) Other 10 (2.3%) 14 (2.1%) 24 (2.2%) Wealth score (Mean (SD)) 8.85 (1.62) 9.03 (1.31) 8.96 (1.44) BMI groups Underweight (< 18.5 kg/m2) 11 (2.5%) 15 (2.3%) 26 (2.4%) Normal (18.5–24.9 kg/m2) 162 (36.6%) 146 (22.1%) 308 (27.9%) Overweight (25–29.9 kg/m2) 174 (39.3%) 207 (31.3%) 381 (34.5%) Obese (≥30 kg/m2) 96 (21.7%) 293 (44.3%) 389 (35.2%) Waist circumference Normal 300 (67.7%) 162 (24.5%) 461 (41.8%) Abnormal (≥102 cm for males, ≥88 cm for females) 143 (32.3%) 499 (75.4%) 642 (58.2%) Waist Hip ratio Normal 152 (34.4%) 205 (31.0%) 357 (32.4%) Abnormal (> 0.9 for males, > 0.85 for females) 290 (65.6%) 456 (68.9%) 746 (67.6%) Smoking status Current 121 (27.3%) 36 (5.4%) 157 (14.2%) Former 104 (23.5%) 41 (6.2%) 145 (13.1%) Never 218 (49.2%) 584 (88.4%) 802 (72.6%) Pack-year categories Never 219 (49.5%) 584 (88.4%) 803 (72.8%) 0–10 67 (15.2%) 35 (5.3%) 102 (9.2%) 10–20 56 (12.7%) 21 (3.2%) 77 (7.0%) 20 + 100 (22.6%) 21 (3.2%) 121 (11.0%) Ever smoked cannabis 72 (16.3%) 24 (3.6%) 96 (8.7%) Exposure to second hand smoke 152 (34.3%) 220 (33.3%) 372 (33.7%) Working in a dusty environment for > 1 year 238 (53.7%) 161 (24.4%) 399 (36.1%) Indoor open fire with coal used for cooking 87 (19.9%) 99 (15.1%) 186 (17.0%) Indoor open fire with wood used for cooking 188 (42.9%) 249 (37.9%) 437 (39.9%) Kerosene used for cooking 163 (37.2%) 249 (37.9%) 412 (37.6%) Indoor air pollutant exposure: coal, wood or kerosene Exposure to one 126 (28.4%) 179 (27.1%) 305 (27.6%) Exposure to two 75 (16.9%) 125 (18.9%) 200 (18.1%) Exposure to all three 54 (12.2%) 56 (8.5%) 110 (10.0%) None 188 (42.4%) 301 (45.5%) 489 (44.3%)
About one-third of the study participants mentioned at least one of the four symptoms - cough, phlegm, wheeze, and breathlessness in the past 12 months. Also, nearly 10% reported a doctor diagnosed respiratory disease (Table 2). 37% had at least one known co-morbidity, the most prevalent conditions being hypertension (28%) and diabetes (15%). Indo-Caribbeans had a higher diabetes prevalence than the Afro-Caribbeans and Mixed/ other ethnic groups (21, 10, and 12% respectively). This is the only health variable observed to be different between the ethnic groups. Gender differences in health status were noted in breathlessness, (p < 0.001) and doctor-diagnosed respiratory diseases (p = 0.03). In each case, the rates were higher in women than in men (Table 2).Variable Male (443) Female (661) Total (1104) Chronic cough 30 (6.8%) 52 (7.9%) 82 (7.4%) Chronic phlegm 13 (2.9%) 27 (4.1%) 40 (3.6%) Wheezing in last 12 months 44 (9.9%) 85 (12.9%) 129 (11.7%) Breathlessness 54 (12.5%) 136 (21.7%) 190 (17.9%) Symptomatic (any single respiratory symptom) 134 (30.2%) 248 (37.5%) 382 (34.6%) Self-reported chronic bronchitis 5 (1.1%) 11 (1.7%) 16 (1.4%) Doctor diagnosed COPD, chronic bronchitis or emphysema 3 (0.7%) 14 (2.1%) 17 (1.5%) Doctor diagnosed asthma 34 (7.7%) 75 (11.3%) 109 (9.9%) Doctor diagnosed respiratory disease 35 (7.9%) 79 (12.0%) 114 (10.3%) Doctor diagnosed any other medical condition 146 (33.0%) 255 (38.6%) 401 (36.3%) Doctor diagnosed heart disease 27 (6.1%) 33 (5.0%) 60 (5.4%) Heart failure 12 (2.7%) 10 (1.5%) 22 (2.0%) Hypertension 112 (25.3%) 202 (30.6%) 314 (28.4%) Diabetes 59 (13.3%) 109 (16.5%) 168 (15.2%) Stroke 5 (1.1%) 4 (0.6%) 9 (0.8%) Lung cancer 0 (0%) 1 (0.2%) 1 (0.1%) Tuberculosis 0 (0%) 0 (0%) 0 (0%) Presence of any single comorbidity 147 (33.2%) 257 (38.9%) 404 (36.6%) Hospitalised as a child for breathing problems prior age 10 6 (1.4%) 10 (1.5%) 16 (1.5%)
Risk factors for low FVC
FVC values were higher in men than women (mean difference = 1070 ml; 95%CI = 991, 1148; p < 0.001). These values were also positively correlated with height (b = 0.052; 95%CI = 0.047, 0.056; p < 0.001) and negatively associated with age (b = − 0.026; 95%CI = − 0.031, − 0.021; p < 0.001).
The mean FVC and FEV1 values adjusted for age, sex, height, and height-squared are tabulated in Table 3 by the potential risk factors. There were significant post-bronchodilator FVC differences by ethnicity (p < 0.001), BMI group (p = 0.024), abnormal waist circumference (p < 0.001), abnormal waist-hip-ratio (p < 0.001), and whether they smoked cannabis (p = 0.004). Indo-Caribbeans showed lower mean FVCs than Afro-Caribbeans and other ethnic groups (Table 3 and Fig. 2). BMI presented a non-linear relation with low FVC. Underweight and obese subjects displayed lower FVCs than those with normal body habitus and overweight people. People with central obesity (abnormal waist circumference and waist-hip ratio) also showed lower FVCs. On the other hand, smokers of cannabis had higher FVC scores than persons who never smoked cannabis. Cigarette smoking status, history of pack-years, second-hand smoking, childhood exposure to smoking, indoor air pollutant exposure, and working in a dusty environment for more than 1 year were not associated with FVC values.Variable Adjusted Pre-BD Mean FEV1 Adjusted Post-BD Mean FEV1 Adjusted Pre-BD Mean FVC Adjusted Post-BD Mean FVC Ethnicity *** *** *** *** Indo-Caribbean 2085 2133 2661 2669 Afro-Caribbean 2212 2268 2853 2880 Mixed/ other 2284 2331 2951 2952 BMI group * * Underweight (< 18.5 kg/m2) 2098 2146 2739 2736 Normal (18.5–24.9 kg/m2) 2198 2239 2859 2845 Overweight (25–29.9 kg/m2) 2200 2257 2821 2852 Obese (≥30 kg/m2) 2119 2175 2693 2718 Waist circumference *** *** *** *** Normal 2261 2300 2923 2917 Abnormalb 2094 2158 2674 2710 Waist Hip ratio *** *** *** *** Normal 2263 2308 2928 2919 Abnormalc 2126 2182 2721 2748 Smoking status Current smoker 2157 2242 2834 2894 Ex-smoker 2158 2196 2757 2769 Never smoker 2176 2223 2784 2791 Smoking pack years Never 2176 2223 2783 2790 0–10 2217 2247 2809 2819 10–20 2152 2232 2795 2824 20+ 2109 2192 2787 2852 Smoking and respiratory symptoms * Never smoker with no symptoms 2201 2257 2812 2819 Never smoker with symptoms 2119 2148 2720 2725 Ever smoker with no symptoms 2211 2261 2859 2876 Ever smoker with symptoms 2087 2173 2717 2780 Ever smoked cannabis * ** No 2167 2220 2777 2791 Yes 2255 2302 2984 2996 Second-hand smoking No 2176 2234 2773 2817 Yes 2160 2200 2796 2777 Indoor air pollutant exposure (coal, wood or kerosene) * * * None 2203 2249 2838 2846 Exposure to one 2119 2188 2712 2742 Exposure to two 2223 2266 2821 2831 Exposure to all three 2089 2132 2735 2753 Worked in a dusty environment for > 1 year No 2183 2227 2780 2784 Yes 2150 2216 2803 2835 Smoking exposure during childhood * No 2207 2250 2801 2818 Yes 2144 2203 2772 2794 Highest level of education *** * *** Primary/none 2137 2197 2747 2775 Secondary 2159 2212 2778 2805 Vocational 2228 2259 2847 2819 University 2363 2397 3027 2974 Education – years of schooling * 0–6 years 2073 2162 2680 2730 7+ years 2182 2230 2801 2811 Current employment status Employed 2195 2240 2805 2815 Not working 2152 2237 2788 2880 House person 2140 2215 2717 2753 Retired 2111 2164 2772 2775 Other 2361 2362 3082 3024
Multiple regression analysis of the risk factors that were significant after adjusting for age, sex, height, and height-squared indicated that post-bronchodilator FVC was lower in those with increased waist circumference (− 172 ml), Indo-Caribbean participants (− 180 ml) and those who were underweight (− 185 ml), and higher in those who smoked cannabis (+ 155 ml) (Table 4).Variables Categories Models with Individual Risk Factorsa Multivariate Modela p-values (Multivariate model) Coefficient (ml) 95% CI Coefficient (ml) 95% CI Ethnicity Afro-Caribbean Baseline < 0.001 Indo-Caribbean −211 −302 −120 −180 −269 −90 Mixed/Other 73 −35 180 79 −27 185 BMIb Normal Baseline 0.01 Underweight −109 −261 44 −185 −330 −40 Overweight 8 −77 93 68 −24 161 Obese − 127 −228 −26 −15 −128 98 Abnormal waist circumferencec Yes −207 − 296 −119 −172 −278 −66 < 0.001 Abnormal waist–hip ratio d Yes − 170 − 246 −95 −71 −145 2 0.057 Ever smoked cannabis Yes 205 67 342 155 27 282 0.018
Risk factors for low pre-bronchodilator FVC were of similar significance to those for post-bronchodilator FVC except that indoor air pollution and levels of education were related to pre-bronchodilator FVC but not to post-bronchodilator FVC (Tables 3, 4 and Additional file 1: Table S2).
FVC and health variables
The mean adjusted FVC and FEV1 scores by the various symptoms and health status variables are listed in Table 5. Participants with known diabetes (p = 0.041), with a history of breathlessness (p = 0.007), and wheeze in the past 12 months (p = 0.040) exhibited lower FVC. Diagnosed respiratory disease, hypertension, cardiac disease, history of cough or phlegm, hospitalization before the age of 10 years, and family history of airway disease were not associated with FVC.Variable Adjusted Pre-BD Mean FEV1 Adjusted Post-BD Mean FEV1 Adjusted Pre-BD Mean FVC Adjusted Post-BD Mean FVC Hospitalisations prior to the age 10 * No 2171 2223 2786 2801 Yes 2246 2244 3042 3032 Known asthma *** *** No 2192 2242 2800 2812 Yes 1967 2049 2675 2727 Known respiratory disease *** *** * No 2195 2244 2803 2815 Yes 1955 2037 2654 2707 Known hypertension No 2153 2197 2806 2820 Yes 2177 2233 2741 2764 Known diabetes * * No 2127 2166 2802 2818 Yes 2179 2233 2709 2727 Known cardiac disease No 2084 2132 2795 2813 Yes 2176 2228 2673 2662 Presence of any known comorbidity * No 2184 2236 2814 2824 Yes 2146 2199 2742 2770 Chronic cough No 2173 2226 2784 2799 Yes 2133 2182 2807 2827 Phlegm No 2172 2223 2792 2806 Yes 2143 2208 2755 2783 Wheeze in the last 12 months *** *** *** * No 2200 2247 2815 2821 Yes 1946 2041 2579 2681 Breathlessness ** ** *** * No 2216 2270 2837 2850 Yes 2071 2121 2678 2708 Family history of airway disease No 2167 2220 2782 2799 Yes 2272 2281 2928 2919
Risk factors for low FEV1
Low post-bronchodilator FEV1 was also independently associated with Indo-Caribbean ethnicity (− 125 ml) and abnormal waist circumference (− 108 ml) (Additional file 1: Table S4). In contrast to FVC, low FEV1 showed an independent association with indoor air pollutant exposure (− 95 ml for all three exposures) but did not show a relation with BMI and cannabis smoking. Further, pre-bronchodilator FEV1 showed associations with abnormal waist-hip ratio (− 69 ml) and highest level of education (+ 168 ml for university education).
Discussion
To our knowledge this is the first published study of lung function in the general population of a Caribbean country and provides new information on the associations of FVC with participant demographics, socio-economic status and morbidity. We found lower FVCs among the Indo-Caribbean population, those with a low BMI and with central obesity. Individuals with a low FVC had more respiratory symptoms.
We observed low FVCs among Indo-Caribbeans compared to Afro-Caribbeans in our study by abut 8% despite the similar prevalence of abnormal waist circumference (57.0% vs. 58.7%; p = 0.751) and a lower prevalence of obesity (30.0% vs. 41.8%; p = 0.008), (Table 6). The lower volumes among Indo-Caribbeans compared with the population of African descendant were consistent with the results from Global differences in lung function by region Prospective Urban Rural Epidemiology (PURE) study [23]. This contrasts with the recently published Canadian Health Measures Survey reference values [24] which showed higher FVCs among those of South Asian compared with those of African descent.Variable Afro-Caribbean Indo-Caribbean Mixed/ Others p-value Gender 0∙110 Male 169 (42.0%) 191 (41.5%) 83 (34.3%) Female 233 (58∙0%) 269 (58.5%) 159 (65.7%) Age group 0.076 40–49 145 (36.1%) 181 (39.3%) 113 (46.7%) 50–59 134 (33.3%) 136 (29.6%) 68 (28.1%) 60–69 80 (19.9%) 95 (20.7%) 32 (13.2%) 70+ 43 (10.7%) 48 (10.4%) 29 (12.0%) BMI groupa 0.008 Underweight 7 (1.7%) 10 (2.2%) 9 (3.7%) Normal 93 (23.1%) 145 (31.5%) 70 (28.9%) Overweight 134 (33.3%) 167 (36.3%) 80 (33.1%) Obesity 168 (41.8%) 138 (30.0% 83 (34.3%) Waist circumferenceb 0.751 Abnormal 236 (58.7%) 262 (57.0%) 144 (59.8%) Waist-Hip ratioc < 0.001 Abnormal 238 (59.2%) 352 (76.5%) 156 (64.7%) Smoking status 0.240 Current 56 (13.9%) 61 (13.3%) 40 (16.5%) Ex 54 (13.4%) 52 (11.3%) 39 (16.1%) Never 292 (72.6%) 347 (75.4%) 163 (67.4%) Smoking pack years 0.244 Never 293 (72.9%) 347 (75.6%) 163 (67.4%) 0–10 35 (8.7%) 41 (8.9%) 26 (10.7%) 10–20 25 (6.2%) 28 (6.1%) 24 (9.9%) 20+ 49 (12.2%) 43 (9.4%) 29 (12.0%) Ever smoked Cannabis < 0.001 Yes 49 (12.6%) 19 (4.2%) 28 (11.7%) Exposure to second-hand smoke 0∙001 Yes 112 (27.9%) 184 (40.0%) 76 (31.4%) Indoor air pollutant exposure < 0.001 Yes 198 (49.2%) 310 (67.3%) 107 (44.2%) Worked in dusty environment > 1 year 0.001 Yes 174 (43.3%) 153 (33.3%) 72 (29.8%) Smoking exposure during childhood 0∙740 Yes 234 (58.2%) 261 (56.8%) 146 (60.3%) Have respiratory symptoms 0.335 Yes 128 (31.8%) 165 (35.8%) 89 (36.7%) Highest level of education < 0.001 Primary / None 190 (47.3%) 243 (52.8%) 88 (36.4%) Secondary 113 (28.1%) 144 (31.3%) 93 (38.4%) Vocational 72 (17.9%) 54 (11.7%) 43 (17.8%) University 27 (6.7%) 19 (4.1%) 18 (7.4%) Years of schooling 0.200 7 or more 368 (91.5%) 405 (88.0%) 220 (90.9%) Current employment status < 0.001 Employed 241 (60.0%) 241 (52.4%) 133 (55.0%) Not working 16 (4.0%) 9 (2.0%) 15 (6.2%) House person 34 (8.5%) 139 (30.2%) 42 (17.4%) Retired 95 (23.6%) 69 (15.0%) 46 (19.0%) Other 16 (4.0%) 2 (0.4%) 6 (2.5%)
FVC in our population showed a nonlinear relation with BMI, comprising low volumes among those with both low and high BMI. Obesity and abnormal waist circumference related reduction in vital capacity can be explained by restriction of inspiration. Obesity-associated reduction in FVC has been observed in many studies and has been attributed to an increased impedance of the chest wall [25–27]. Studies have also shown that a 1 cm increment in waist circumference can decrease FVC by 13 ml [28]. Waist circumference is considered as a superior indicator of intra-abdominal fat [29] and may be a good gauge of its effect on diaphragm function and other ventilatory mechanics. When we adjusted FVC measures for both BMI and waist circumference the association of low FVC with a high BMI disappeared and that with waist circumference was essentially unchanged, suggesting that the link between a low FVC and a high BMI is mediated largely through mechanical effects of an increase in intra-abdominal fat. The association of a low FVC with a low BMI, however, was strengthened in the adjusted model, suggesting a more direct association. Low vital capacities have also been reported to be associated with low birth weight [30], though we have no estimate of birth weight in this population.
An increased FVC among cannabis smokers has also been reported in previous studies [31–33]. The exact cause for this increase is unclear but could reflect a “healthy smoker” effect, those with poor lung function being less likely to take up smoking cannabis. The effect of cannabis on FVC and the lack of association with FEV1 could be explained by training effects on the respiratory muscles with the habitual deep inhalations during cannabis smoking, and the likely acute bronchodilatory effects of delta-9-tetrahydrocannabinol (THC) [34]. These findings warrant careful interpretation given the potential adverse public health implications of long-term cannabis use including emphysematous bullae [35] and a twofold increased odds of obstructive lung disease [32]. Apart from cigarette smoking, the statistically nonsignificant associations with environmental factors such as exposure to indoor air pollution or solid fuel and working in a dusty environment on FVC have been observed in other studies as well [36].
We found that participants who had a low FVC had a history of wheezing or shortness of breath. This relationship has been published in previous studies [37, 38]. A low FVC was also associated with comorbidities especially diabetes. Earlier studies have found that individuals in the lowest quartile for FVC are more likely to develop insulin resistance [8] and diabetes [9] over time. A meta-analysis of 40 publications has shown a significantly lower FVC and FEV1 with preserved FEV1/FVC ratio among diabetic patients [39].
Although low socioeconomic status and poor education have been associated with reduced ventilatory function and chronic lung disease, this was not found in the current study. This may be due to either high per capita gross domestic product (GDP US$ 17,879 in 2015) with minor economic inequalities (GINI index 40.3 in 2010) among the local community (Data was sourced from the IMF press release no. 17/423. http://www.imf.org/en/News/Articles/2017/11/06/pr17423-imf-executive-board-concludes-article-iv-consultation-with-trinidad-and-tobago) compared to other developing countries or ineffectiveness of the tools used to distinguish the economic variations in this population. Although the wealth scale that we used has been shown to have good reliability [18] and has been associated with educational attainment, the majority of the sample possessed eight or more out of ten household amenities. This was similar to the situation seen in wealthy countries like Saudi Arabia [40]. The scale may need customization.
Limitations of the current study include the cross-sectional nature of the research, reliance on self-reported data and limited tools to measure the socioeconomic variations in the local population. However, there were many strengths such as our high response and cooperation rates. The diverse and evenly distributed ethnic distribution in the population, which was reflected in the sample, allowed for the examination of ethnic differences. Other strengths included the application of robust BOLD methodology, sound participant sampling, and quality assured spirometry. Most importantly we avoided the arbitrary use of ‘normal’ values for lung function assessment.
Conclusions
Low FVC was associated with ethnicity, central obesity, chronic respiratory symptoms, and comorbidities like diabetes. Longitudinal studies are required to estimate the mortality and morbidity risk with diminished FVCs and also to compare the health effects of reduced FVC compared to reduced static lung volumes. Identifying individuals with low FVC may have clinical and public health importance and a better understanding of this condition and its origins is needed.
Additional file
Untitled section
Abbreviations
- ATS
- American thoracic society
- BMI
- Body mass index
- BOLD
- Burden of obstructive lung disease
- FEV1
- Forced expiratory volume in one second
- FVC
- Forced vital capacity
- GDP
- Gross domestic product
- PURE
- Prospective urban rural epidemiology study
- THC
- Tetrahydrocannabinol
Acknowledgements
We sincerely thank the BOLD central office, Imperial College, London for guidance and spirometry quality control, BOLD Trinidad and Tobago Steering Committee for technical advisory support, The Central Statistical Office (CSO) Trinidad and Tobago for providing population sampling support, and The Thoracic Society of Trinidad and Tobago (TSOTT) for professional collaboration.
Funding
The BOLD Trinidad and Tobago study was supported by a grant from the Ministry of Health, the Republic of Trinidad and Tobago, and a Research and Development grant from The University of the West Indies, St. Augustine. Some financial or other support was also obtained from Astra-Zeneca, Boehringer Ingelheim, Glaxo Smith Kline and Novartis. The BOLD coordinating centre was funded by the Wellcome Trust (085790/Z/08/Z). The funding bodies played no role in study design and data collection, interpretation of data or writing of the manuscript.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Notes
Ethics approval and consent to participate
Ethical approval was granted by the ethics committees of the Faculty of Medical Sciences of the University of the West Indies and the Ministry of Health, Trinidad and Tobago. All participants signed the written consent to participate.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.